Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_assertion type Assertion NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_head.
- NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_assertion description "[CLU immunoreactivity may be helpful as a supplementary criterion to better assess the tumors propensity to relapse in breast carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_provenance.
- NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_assertion evidence source_evidence_literature NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_provenance.
- NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_assertion SIO_000772 17203891 NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_provenance.
- NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_assertion wasDerivedFrom lhgdn-20090331 NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_provenance.
- NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_assertion wasGeneratedBy ECO_0000203 NP165370.RASiyh3QS9EeAjrdU1Q3XTt0QbRJVkL2SqZpd6Q9Pe3GQ130_provenance.